LINCOLN NATIONAL LIFE INSURANCE CO /IN/
The Lincoln National Life Insurance Company (LNL) filed an 8-K under Item 4.02 disclosing non-reliance on previously issued financial statements. The board, after discussion with EY, determined audited 2024-2025 annual and 2024-2026 interim financials require restatement due to a mechanical error in a recurring journal entry recording the ceded portion of a shadow adjustment, initially made in Q4 2023. The error overstated AOCI by approximately $1.2 billion at Dec 31, 2025 and $1.9 billion at Dec 31, 2024. Management also concluded a material weakness existed in internal control over financial reporting as of Dec 31, 2025.
- Restatement covers audited 2024-2025 annual and eight interim periods from Q1 2024 through Q2 2026.
- AOCI overstated by ~$1.2B (Dec 2025) and ~$1.9B (Dec 2024) on consolidated balance sheets.
- Error was mechanical, involving no judgments, estimates, or assumptions, tied to a Q4 2023 reinsurance agreement with an affiliate.
- No impact to statutory financials, statutory surplus, RBC ratio, or dividend capacity; shadow accounting is GAAP-only.
- Material weakness in internal control over financial reporting as of Dec 31, 2025; management's ICFR report no longer reliable.
Price data unavailable.
A $1.9B AOCI overstatement and material-weakness disclosure at a major insurer's life subsidiary signals control failures, though the GAAP-only nature spares statutory capital.
The restatement is GAAP-only and does not affect LNL's statutory surplus or RBC ratio, limiting the regulatory-capital impact for the insurance subsidiary.
Material weakness in internal control over financial reporting as of Dec 31, 2025. Additional information or subsequent events could require further adjustments or delay the restated filings.